Heart sounds

Fujitsu and University of Tokyo Hospital Embark on Joint Research into AI to Aid the Fight Against Heart Disease

Monday, October 11, 2021 - 2:29am

Since December 2019, Fujitsu has been making progress with research and development of proprietary AI technology(2) in collaboration with the University of Tokyo Hospital.

Key Points: 
  • Since December 2019, Fujitsu has been making progress with research and development of proprietary AI technology(2) in collaboration with the University of Tokyo Hospital.
  • The AI will be used in clinical field research to estimate the presence or absence of abnormal heart movements based on the data of patients undergoing electrocardiographic procedures at the University of Tokyo Hospital.
  • Based on the electrocardiogram data of patients examined at the University of Tokyo Hospital, Fujitsu and the University of Tokyo Hospital will verify the effectiveness of detection of abnormal heart movement by AI.
  • Through its joint research with the University of Tokyo Hospital, Fujitsu will continue to actively promote research and development of AI to detect various heart diseases.

Reimagining Telehealth & Care at Belmont Village Senior Living: Keeping Residents Healthy, Safe, and Out of Emergency Rooms During COVID-19 and Beyond

Thursday, September 2, 2021 - 3:08pm

Access to the services is also free of charge to residents of participating Belmont Village locations, allowing them high-quality access to health care from the comfort of their communities.

Key Points: 
  • Access to the services is also free of charge to residents of participating Belmont Village locations, allowing them high-quality access to health care from the comfort of their communities.
  • Since the programs launch in 2020, Belmont Village has seen a significant reduction in the number of visits to emergency rooms and outside urgent care facilities for participating residents; reducing discomfort, risk and stress for residents and loved ones.
  • When COVID-19 hit and emergency rooms were either filled or unable to take non-COVID cases, the critical importance of telemedicine for our residents became immediately clear.
  • Our partnership with Tembo for our Urgent Care Telemedicine Program reimagines the possibilities of clinical care for senior living communities, adds Will.

Eko’s AI Analysis Algorithm Validated as a Clinical Tool for Detecting Heart Murmurs

Monday, May 10, 2021 - 1:00pm

The findings suggest utility of the FDA-cleared Eko AI algorithm as a frontline clinical tool to aid clinicians in screening for cardiac murmurs that may be caused by valvular heart disease.\nAlgorithm performance for detecting murmurs was found to have sensitivity of 90.0% and specificity of 91.4%, when excluding grade 1 murmurs which are difficult to hear.

Key Points: 
  • The findings suggest utility of the FDA-cleared Eko AI algorithm as a frontline clinical tool to aid clinicians in screening for cardiac murmurs that may be caused by valvular heart disease.\nAlgorithm performance for detecting murmurs was found to have sensitivity of 90.0% and specificity of 91.4%, when excluding grade 1 murmurs which are difficult to hear.
  • The NIH-sponsored, multisite study published in the Journal of the American Heart Association was the largest study on AI analysis of cardiac murmurs.
  • \xe2\x80\x9cIt takes expert clinicians many years to master the art of hearing and interpreting heart murmurs, and there is still a lot of variability.
  • \xe2\x80\x9cNow for the first time, artificial intelligence is being applied to stethoscopic heart sounds to improve the auscultation skills of health care professionals.

Global Stethoscope Markets, Analysis 2016-2019 & Forecasts 2020-2027

Friday, September 25, 2020 - 8:15pm

The global stethoscope market size is anticipated to reach USD 593.4 million by 2027, expanding at a CAGR of 4.9%

Key Points: 
  • The global stethoscope market size is anticipated to reach USD 593.4 million by 2027, expanding at a CAGR of 4.9%
    In terms of revenue, the teaching type segment dominated the market in 2019.
  • Growing prevalence of cardiovascular and respiratory disorders, and increasing geriatric population are driving the market.
  • Stethoscope is widely used for heart auscultation (listening to the heart sound) during diagnosis of cardiac illness.
  • For instance, 3M has launched Single-Patient Stethoscope' to overcome the issues related to disposable stethoscopes such as, inadequate audibility and discomfort faced by healthcare professionals.

Global Stethoscope (Cardiovascular, Neonatal, Infant, Pediatric, Fetal, Electronic, Teaching) Market Size, Share & Trends Analysis Report 2020 - 2027 - ResearchAndMarkets.com

Tuesday, September 22, 2020 - 11:43am

The "Stethoscope Market Size, Share & Trends Analysis Report by Type (Cardiovascular, Neonatal, Infant, Pediatric, Fetal, Electronic, Teaching), by Region (North America, Europe, APAC, Latin America, MEA), and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Stethoscope Market Size, Share & Trends Analysis Report by Type (Cardiovascular, Neonatal, Infant, Pediatric, Fetal, Electronic, Teaching), by Region (North America, Europe, APAC, Latin America, MEA), and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.
  • The global stethoscope market size is anticipated to reach USD 593.4 million by 2027, expanding at a CAGR of 4.9%
    Growing prevalence of cardiovascular and respiratory disorders, and increasing geriatric population are driving the market.
  • Increase in The incidence of numerous cardiovascular and pulmonary diseases in several countries is anticipated to impact market growth over the forecast period.
  • Stethoscope is widely used for heart auscultation (listening to the heart sound) during diagnosis of cardiac illness.

eMurmur receives CE mark certification for its heart murmur detection solution

Wednesday, June 12, 2019 - 3:46pm

OTTAWA, June 12, 2019 /PRNewswire/ - eMurmur announced today that its flagship "eMurmur ID" solution has received the CE mark certification.

Key Points: 
  • OTTAWA, June 12, 2019 /PRNewswire/ - eMurmur announced today that its flagship "eMurmur ID" solution has received the CE mark certification.
  • eMurmur ID is a mobile and cloud solution which operates in conjunction with a 3rdparty electronic stethoscope.
  • It uses advanced machine learning to identify and classify pathologic and innocent heart murmurs, the absence of a heart murmur, and S1, S2 heart sounds.
  • eMurmur launched an early access program available at https://emurmur.com/clinical , designed to give early adopters full access to eMurmur ID.

FDA grants clearance for a heart murmur detection solution on a personal mobile device

Tuesday, May 14, 2019 - 3:53pm

OTTAWA, May 14, 2019 /PRNewswire/ -eMurmur today announced that its flagship "eMurmur ID" solution has received FDA clearance, enabling a new era in heart murmur detection.

Key Points: 
  • OTTAWA, May 14, 2019 /PRNewswire/ -eMurmur today announced that its flagship "eMurmur ID" solution has received FDA clearance, enabling a new era in heart murmur detection.
  • eMurmur ID is a mobile and cloud solution which operates in conjunction with a 3rdparty electronic stethoscope.
  • It uses advanced machine learning to identify and classify pathologic and innocent heart murmurs, the absence of a heart murmur, and S1, S2 heart sounds.
  • The end-to-end solution is comprised of AI-based analytics, a mobile app, and a web portal (all HIPAA compliant).

Northwestern Medicine and Eko Partner to Improve Valvular Heart Disease Screening Using Machine Learning Algorithms

Thursday, March 7, 2019 - 3:00pm

The study aims to demonstrate that Eko's digital stethoscopes and AI algorithms can interpret heart sounds accurately to help screen for pathologic heart murmurs and valvular heart disease.

Key Points: 
  • The study aims to demonstrate that Eko's digital stethoscopes and AI algorithms can interpret heart sounds accurately to help screen for pathologic heart murmurs and valvular heart disease.
  • Machine learning can combine the data from tens of thousands of heart sound patterns and provide that accuracy to physicians anywhere.
  • "Northwestern Medicine is the perfect incubator for partnering with companies using machine learning in a variety of clinical settings, and it's through advancements like this that we will become even better physicians."
  • Eko is applying machine learning in the fight against heart disease.

Know the signs: Tips for recognizing and managing heart disease in dogs

Monday, January 7, 2019 - 10:30am

Acquired diseases affecting the heart valves or heart muscle can eventually cause the heart to fail and result in inadequate blood flow.

Key Points: 
  • Acquired diseases affecting the heart valves or heart muscle can eventually cause the heart to fail and result in inadequate blood flow.
  • A thorough physical exam, including listening to the heart and lungs with a stethoscope, is how your veterinarian can determine that heart disease may be present in your dog.
  • What is the difference between heart disease and heart failure?
  • It is important to know that heart disease does not mean your dog is in heart failure.